Lipocine Inc. — Director's Dealing 2021

Jun 10, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lipocine Inc. (LPCN)
CIK: 0001535955
Period of Report: 2021-06-09

Reporting Person: Ono Richard Dana (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-09	Common Stock (Right to Buy)	$1.26	A	22000	Acquired	2031-06-09	Common Stock (22000)	Direct

Footnotes

F1: 100% vesting one year from date of grant